ScinoPharm Taiwan is an API manufacturer based in Taiwan. It holds 71 active US drug master files. Its most recent recorded inspection, by US FDA, closed on 25 October 2022 as NAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Taiwan, Taiwan | 3002840477 |
| Molecule | Regulators | Docs |
|---|---|---|
| Docetaxel | SFDA (Saudi Arabia), US FDA | 5 |
| Gemcitabine | SFDA (Saudi Arabia), US FDA | 3 |
| Olaparib | SFDA (Saudi Arabia), US FDA | 3 |
| Paclitaxel | SFDA (Saudi Arabia), US FDA | 3 |
| Azacitidine | SFDA (Saudi Arabia), US FDA | 2 |
| Cladribine | SFDA (Saudi Arabia), US FDA | 2 |
| Decitabine | US FDA | 2 |
| Exemestane | SFDA (Saudi Arabia), US FDA | 2 |
| Galantamine | US FDA | 2 |
| Irinotecan | SFDA (Saudi Arabia), US FDA | 2 |
| Letrozole | SFDA (Saudi Arabia), US FDA | 2 |
| Pemetrexed | US FDA | 2 |
| Topotecan | SFDA (Saudi Arabia), US FDA | 2 |
| Abemaciclib | US FDA | 1 |
| Alectinib | US FDA | 1 |
| Alpelisib | US FDA | 1 |
| Anastrozole | US FDA | 1 |
| Apixaban | US FDA | 1 |
| Apremilast | US FDA | 1 |
| Atazanavir | US FDA | 1 |
| Benazepril | US FDA | 1 |
| Bimatoprost | US FDA | 1 |
| Bivalirudin | US FDA | 1 |
| Bortezomib | US FDA | 1 |
| Brexpiprazole | US FDA | 1 |
| Capecitabine | US FDA | 1 |
| Cedazuridine | US FDA | 1 |
| Celecoxib | US FDA | 1 |
| Clofarabine | US FDA | 1 |
| Dantrolene | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | 3 | None |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. ScinoPharm Taiwan comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.